Insider trade

Officer sold ~$888K of WST shares in the open market

Traded Sep 14, 2026 · Filed Sep 15, 2026

~$888K
Reported value · 2,500 sh @ $355.00: 22K
Holds after · shares reported: +2.8%
stock since the trade · S&P 500 +0.4%, $355.20 → $365.01 on Oct 1

Why it stands out

West Pharmaceutical Services's Sr. VP & Chief HR Officer sold $888K of West Pharmaceutical Services shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 14, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 15, 2026

Officer$500K–$1M

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$887,500

Shares × reported transaction price

Timing vs results

53 days after results of Jul 23, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $355.20 on Sep 14, 2026, within 3% of its 52-week high, after a 4% rise over the previous 30 trading days

52-week range $230.95 (Feb 3, 2026) to $365.74 (Jul 2, 2026), 92% of the way up, from 251 adjusted closes. 30 trading days earlier: $340.96 on Jul 31, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on May 5, 2025 in the U.S. District Court, E.D. Pennsylvania. A filing is an allegation, not a finding.

NEW ENGLAND TEAMSTERS PENSION FUND v. WEST PHARMACEUTICAL SERVICES, INC., docket 2:25-cv-02285, via CourtListener (court records). Nature of suit 850, company named as first defendant